HCG
Healthcare Global Enterprises Limited (HCG) Stock Analysis
Healthcare Global Enterprises Limited is an Indian cancer-care hospital chain operating multidisciplinary oncology centers. It provides radiation, surgical, and medical oncology services. The company serves patients across South and Central India. It is listed on Indian stock exchanges.
Healthcare › Medical Care Facilities
₹587.00
-10.74% 1W | -14.60% 52W
Market Cap
8.8k CR
P/E Ratio
378.7
52W High
₹804.6
52W Low
₹513.3
Div. Yield
0%
Beta
-0
50 DMA
₹694.2
200 DMA
₹628.8
Profit Margin
0.9%
Inst. Own.
19.6%
⚠️ BREAKDOWN
⚠️ BREAKDOWN
Fundamentals
Profit & Loss
| Metric | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 461 | 487 | 470 | 495 | 526 | 554 | 559 | 585 | 613 | 647 | 633 | 652 | 695 |
| Expenses | 386 | 402 | 391 | 403 | 435 | 451 | 470 | 480 | 505 | 524 | 524 | 527 | 573 |
| Operating Profit | 74 | 85 | 79 | 92 | 91 | 102 | 88 | 106 | 108 | 123 | 110 | 125 | 122 |
| OPM % | 16% | 17% | 17% | 19% | 17% | 18% | 16% | 18% | 18% | 19% | 17% | 19% | 18% |
| Other Income | 3 | 3 | 6 | 9 | 9 | 11 | 6 | 10 | 8 | 3 | -10 | -18 | 13 |
| Interest | 26 | 27 | 29 | 27 | 34 | 36 | 41 | 44 | 45 | 44 | 45 | 43 | 40 |
| Depreciation | 41 | 43 | 44 | 46 | 47 | 50 | 57 | 58 | 58 | 63 | 61 | 63 | 70 |
| Profit before tax | 11 | 18 | 11 | 28 | 19 | 28 | -3 | 14 | 12 | 20 | -6 | 1 | 25 |
| Tax % | 65% | 40% | 69% | 17% | 28% | 25% | -335% | 50% | 50% | -4% | 30% | -223% | 34% |
| Net Profit | 4 | 11 | 3 | 23 | 14 | 21 | 8 | 7 | 6 | 21 | -8 | 4 | 16 |
| EPS in Rs | 0.52 | 0.92 | 0.39 | 1.44 | 0.82 | 1.22 | 0.47 | 0.50 | 0.32 | 1.09 | -0.63 | 0.15 | 0.92 |
| Metric | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 519 | 584 | 700 | 829 | 976 | 1,092 | 1,009 | 1,395 | 1,691 | 1,908 | 2,218 | 2,538 | 2,627 |
| Expenses | 443 | 499 | 595 | 713 | 864 | 936 | 887 | 1,161 | 1,394 | 1,581 | 1,835 | 2,080 | 2,147 |
| Operating Profit | 76 | 85 | 105 | 116 | 112 | 157 | 122 | 234 | 297 | 327 | 384 | 459 | 480 |
| OPM % | 15% | 15% | 15% | 14% | 11% | 14% | 12% | 17% | 18% | 17% | 17% | 18% | 18% |
| Other Income | 0 | -2 | 10 | 25 | 10 | 10 | -72 | 110 | 15 | 24 | 39 | -11 | -13 |
| Interest | 34 | 38 | 23 | 42 | 70 | 138 | 119 | 98 | 104 | 109 | 155 | 177 | 171 |
| Depreciation | 39 | 44 | 57 | 71 | 85 | 148 | 159 | 158 | 163 | 174 | 211 | 244 | 257 |
| Profit before tax | 3 | 0 | 35 | 27 | -33 | -119 | -229 | 88 | 45 | 68 | 57 | 27 | 40 |
| Tax % | -56% | -730% | 34% | 38% | -7% | 5% | -3% | 56% | 61% | 39% | 14% | 15% | |
| Net Profit | 5 | 2 | 23 | 17 | -31 | -125 | -221 | 39 | 18 | 41 | 49 | 23 | 33 |
| EPS in Rs | 0.11 | -0.16 | 2.44 | 2.23 | -2.66 | -11.36 | -14.58 | 3.65 | 1.99 | 3.27 | 3.01 | 0.92 | 1.53 |
| Dividend Payout % | -0% | -0% | -0% | -0% | -0% | -0% | -0% | -0% | -0% | -0% | -0% | -0% |
Growth — CAGR
| Metric | 3Y | 5Y | 10Y |
|---|---|---|---|
| Revenue CAGR | 14.0% | 20.0% | 16.0% |
| Profit CAGR | -1.0% | 18.0% | 39.0% |
Shareholding Pattern
Promoters62.46%
FIIs2.16%
DIIs13.22%
Public22.17%
Promoters63.78%
FIIs3.59%
DIIs18.36%
Public14.28%
Promoters63.77%
FIIs3.22%
DIIs18.30%
Public14.71%
Promoters64.21%
FIIs2.76%
DIIs18.91%
Public14.15%
Promoters64.21%
FIIs2.73%
DIIs19.20%
Public13.86%
Promoters71.37%
FIIs6.37%
DIIs5.53%
Public16.71%
Promoters71.28%
FIIs6.74%
DIIs8.52%
Public13.45%
Promoters71.22%
FIIs2.44%
DIIs12.48%
Public13.86%
Promoters64.21%
FIIs2.76%
DIIs18.91%
Public14.15%
Promoters64.21%
FIIs2.73%
DIIs19.20%
Public13.86%
HCG
Holdings Analysis
Key strengths & risk signals
55
Overall
59
Fundamental
52
Technical
Risks (4)
Cannot calculate PEG - insufficient growth data.
WEAK POSITION! Current price (579.4) is below both moving averages.
WEAK YEAR! Stock declined 15.0% in the last year.
NEGATIVE MOMENTUM! Price declined across timeframes - down 14.9% (1 week), 16.5% (1 month), 10.4% (3 months).
Strengths (4)
PERFECT RECORD! Revenue has grown consistently every year. Exceptional business stability.
BULLISH TREND! 50-day average (695.9) is above 200-day average (629.1) - positive signal.
OVERSOLD! RSI at 25.4 - potential bounce opportunity.
MARKET ALIGNED! Beta of 1.00 - moves with the market.
Fundamental & Technical Analysis
55Overall
59Fundamental
52Technical
Fundamental Breakdown
Growth Quality
13/30
Revenue CAGR: 14.6% (GOOD, 11/15). Profit CAGR: -22.3% (DECLINING, 2/15).
Profit Margin
2/10
LOW MARGIN! 0.9% profit margin - thin profits.
PEG Valuation
1/10
Cannot calculate PEG - insufficient growth data.
Dividend Yield
3/10
NEGLIGIBLE DIVIDEND! 0% yield - little to no income.
Debt to Equity
10/10
VERY LOW DEBT! D/E of 0.00 - excellent financial health.
Public Holding
20/20
VERY LESS PUBLIC HOLDING! 15.59% public ownership - strong promoter/institutional control.
Stability Index
10/10
PERFECT RECORD! Revenue has grown consistently every year. Exceptional business stability.
Technical Breakdown
Moving Averages
12/10
BULLISH TREND! 50-day average (694.2) is above 200-day average (628.8) - positive signal.
Price Position
2/10
WEAK POSITION! Current price (587.0) is below both moving averages.
Trend Pattern
10/20
BREAKDOWN! Stock has broken below support levels - weakness present.
52W Performance
2/10
WEAK YEAR! Stock declined 14.6% in the last year.
Volume Sentiment
15/30
BEARISH SENTIMENT! In last 30 days: 11 up days, 19 down days. Avg volume on up days: 154,629 vs down days: 169,758. Ratio: 0.91x
RSI
5/5
OVERSOLD! RSI at 28.5 - potential bounce opportunity.
52W Range
2/5
LOWER HALF! Trading at 25.3% of 52W range - weakness visible.
Momentum
1/5
NEGATIVE MOMENTUM! Price declined across timeframes - down 10.7% (1 week), 15.4% (1 month), 11.1% (3 months).
Beta
3/5
MARKET ALIGNED! Beta of 1.00 - moves with the market.
HCG
Concall / Investor Presentation
Earnings call transcripts & AI summaries
| Quarter | Concall | Summary |
|---|---|---|
| Q1FY272026-08-10 | Concall PDF | |
| Q4FY262026-05-26 | Concall PDF | |
| Q3FY262026-02-13 | Concall PDF | |
| Q2FY262025-12-11 | Concall PDF |
Peer Comparison
Healthcare · Medical Care Facilities · 8 stocks
| Stock | Price | P/E | Profit Margin | Revenue CAGR 5Y | Profit CAGR 5Y | 52W Change | Stock Strength | Trendline | YoY Profit | QoQ Profit | YoY Revenue | QoQ Revenue |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HCG | ₹587.00 | 378.7 | 0.9% | 14.6% | -22.3% | -14.6% | 55 | BREAKDOWN | +187.5% | +527.3% | +13.3% | +6.6% |
| YATHARTH | ₹983.90 | 52.3 | 13.2% | 32.0% | 38.7% | +21.7% | 84 | CONSOLIDATING UP | +12.1% | -0.8% | +51.5% | +15.0% |
| JLHL | ₹242.00 | 43.8 | 12.0% | 18.9% | 38.6% | -16.6% | 59 | BREAKDOWN | -14.6% | -25.9% | +16.4% | +6.0% |
| PARKHOSPS | ₹241.20 | 36.7 | 16.1% | 9.6% | 5.5% | +59.2% | 64 | BREAKDOWN | +42.2% | +16.4% | +19.3% | +3.3% |
| KOVAI | ₹5,973.00 | 25.9 | 15.6% | 18.2% | 28.3% | +129.2% | 73 | BREAKDOWN | +20.8% | +15.7% | +15.3% | +4.3% |
| NEPHROPLUS | ₹617.10 | 72.8 | 8.1% | 33.9% | – | +31.8% | 58 | BREAKDOWN | +35.0% | +5.3% | +23.7% | +6.1% |
| RAINBOW | ₹1,246.70 | 44.4 | 15.7% | 13.1% | 9.7% | -8.0% | 61 | BREAKDOWN | +13.3% | -21.3% | +33.2% | +2.2% |
| JSLL | ₹384.70 | 20.3 | 27.8% | 57.7% | 87.3% | -47.2% | 63 | BREAKDOWN | +28.5% | +46.1% | +28.7% | +4.1% |
Data from TradeAlone · Updated daily
HCG News
Healthcare Global Enterprises Limited (NSE: HCG) clears resistance, gains 5% intraday2026-08-10Healthcare Global Enterprises Limited Q1 FY27: Revenue Up 13%, Adjusted Ebitda Grows 20%2026-08-06Healthcare Global Enterprises Limited (HCG) shows pressure after breakout, falls 5% intraday2026-07-15Healthcare Global Enterprises Limited (NSE: HCG) climbs 5% intraday2026-06-30Healthcare Global Enterprises Limited (HCG) Launches Cancer Hospital in North Bengaluru2026-05-19
